期刊文献+

抗肿瘤药物载体的研究进展 被引量:1

下载PDF
导出
出处 《生物骨科材料与临床研究》 CAS 2006年第5期32-34,共3页 Orthopaedic Biomechanics Materials and Clinical Study
基金 湖北省科技攻关重大项目(2002AA105A06)
  • 相关文献

参考文献15

  • 1[1]Rowland GF,Axton CA,Baldwin RW,et al.Antitumor properties of vindesine monoclonal antibody conjugates[J].Cancer Immunol Innumolther,1985,19 (1):1-7.
  • 2[2]Kaneiko Y.Thyrotropin-daunomycin conjugate shows receptor mediated cytotoxicity in cultured thyroic cells[J].Horm Metav Res,1981,13 (2):110-114.
  • 3[3]Debs RJ,Duzgunes N,Brunette EN,et al.Liposome associated tumor necrosis factor retains bioactivity in the presence of neutralizing antitumor necrosis factor antibodies[J].J Immunol,1989,143 (4):1192-1197.
  • 4[4]Gal D,Ohashi M,MacDonald PC,et al.Low density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms[J].Am J Obstet Gyneco,1981,139 (8):877-885.
  • 5[5]Raul C Maranhao,Bermardo Garicichea.Plasma kintics and biodistribution of a lipid emulsion resembling low density lipoprotein in patients with acute leukemia[J].Cancer Res,1994,54:4660
  • 6[6]Viktoriya VS,Ina R,Rolf H,et al.Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles.Biomaterials,2006,27:3147 ~ 3153.
  • 7[7]Frankenburg EP,Goldstein SA,Bauer TW,et al.Biomechanical and histological evaluation of a calciumphosphate cement.J Bone Joint SurgAm,1998,80 (8):1112124.
  • 8[8]Wehanced TJ,Ergun C,Doremus RH,et al.Enhanced functions ofosteoblasts on nanophase ceramics.Biomaterials,2000,21 (17):1803810.
  • 9卜碧涛,杨明山,徐金枝,高波廷,潘邓记,蔡玉祥.长期使用泼尼松治疗重症肌无力有效性及安全性的前瞻性研究[J].中华神经科杂志,2000,33(1):28-31. 被引量:37
  • 10戚晓东,齐春莲,王舒宝,单吉贤.微颗粒活性炭在乳癌根治术中的应用[J].实用癌症杂志,1994,9(4):223-224. 被引量:5

二级参考文献1

共引文献130

同被引文献27

  • 1汪冰,丰伟悦,赵宇亮,邢更妹,柴之芳,王海芳,贾光.纳米材料生物效应及其毒理学研究进展[J].中国科学(B辑),2005,35(1):1-10. 被引量:100
  • 2钱倩,王伯瑶.纳米药物载体在医药领域中的研究进展[J].济宁医学院学报,2006,29(2):82-84. 被引量:11
  • 3严文辉,周汉新,李富荣.纳米磁靶向药物载体在肿瘤治疗中的研究进展[J].中国药房,2007,18(4):305-307. 被引量:15
  • 4Fischer HC, Chan WC. Nanotoxicity: the growing need for in vivo study[J]. Current Opinion in Biotechnology, 2007, 18(6):565.
  • 5Bystrzejewska-Piotrowska G, Golimowski J, Urban PL.Nanoparticles: Their potential toxicity, waste and environmental management[J]. Waste Management, 2009,9 (29) : 2 587.
  • 6Faraji AH, Wipf E Nanoparticles in cellular drug delivery [J]. Bioorganic & Medicinal Chemistry, 2009, 17 (8) : 2 950.
  • 7Nel AE, Madler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano-bio interface[J]. Nat Mater, 2009,8 ( 7 ) : 543.
  • 8Aillon KL, Xie Y, El-Gendy N, et al. Effects of nanomaterial physicochemical properties on in vivo toxicity[J]. Advanced Drug Delivery Reviews, 2009,61 (6) : 457.
  • 9Service RF. Nanomaterials show signs of toxicity[J]. Science, 2003,300 (5 617) : 243.
  • 10Klaus U, Catrin A, Lars-Oliver K, et al. Cellular response to nanoparticles: target structures and mechanisms [J]. Nanotoxicology, 2007,1 ( 1 ) : 52.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部